Description
Ipamorelin peptide is a selective growth hormone secretagogue widely studied for its ability to stimulate the natural release of growth hormone through activation of the ghrelin (GHS-R1a) receptor. Unlike some other growth hormone secretagogues, Ipamorelin has been investigated for its high receptor selectivity and its ability to promote endogenous growth hormone secretion with minimal influence on other pituitary hormones. Ipamorelin research continues to explore its role in endocrine function, metabolism, body composition, and healthy aging.
Current Ipamorelin peptide research has examined its effects on growth hormone secretion, insulin-like growth factor-1 (IGF-1) production, and the physiological pathways involved in muscle biology, tissue recovery, and metabolic regulation. Numerous Ipamorelin studies have investigated its interaction with ghrelin receptors and its potential influence on protein synthesis, body composition, energy metabolism, and endocrine signaling. Researchers continue to evaluate Ipamorelin for its pharmacological profile, receptor activity, and long-term biological mechanisms, making it one of the most extensively studied growth hormone research peptides.
As interest in peptide-based hormone research continues to expand, Ipamorelin peptide remains an important investigational compound across multiple areas of biomedical science. Ongoing preclinical and clinical studies continue to improve the scientific understanding of Ipamorelin, its mechanisms of action, and its potential applications in growth hormone physiology, metabolic research, and age-related endocrine science.
Ipamorelin is intended for laboratory and scientific research purposes only. This investigational research peptide is not approved for human consumption or therapeutic use.







Ryan B. –
Reliable service and excellent communication from start to finish. Used for growth hormone research applications.